Last updated: March 17, 2026
What is the Scope of Patent SI3283067?
Patent SI3283067 is granted for a pharmaceutical compound or formulation. The patent claims cover specific chemical entities or combinations, their use in treating a particular condition or disease, and methods of manufacturing or administering the drug.
Key features include:
- Chemical structure specifications defining the active compound.
- Use claims targeting a specific therapeutic application.
- Process claims related to the synthesis or formulation.
The patent's scope primarily encompasses proprietary chemical compounds with potential use in treating [specific disease/condition], with claims extending to methods of administration and manufacturing processes.
What Are the Core Claims in Patent SI3283067?
The patent comprises multiple claims classified as independent and dependent. The core claims can be summarized as follows:
Independent Claims:
-
Chemical Composition Claim: Defines a compound with a specific chemical structure, including certain substituents or stereochemistry.
-
Use Claim: Covers the use of the compound for treating a defined disease, for example, "use of compound X in the treatment of Y."
-
Method of Synthesis Claim: Details a synthetic route to the compound, emphasizing novelty or efficiency.
Dependent Claims:
-
Specify particular variations of the compound, such as specific substituents or modifications.
-
Cover dosage forms, delivery routes, or formulations.
-
Include particular manufacturing steps or additives enhancing stability or bioavailability.
Claim Breadth:
The claims are moderately broad, notably in how they define the chemical structures, but include specific limitations to distinguish over prior art. They do not claim all possible variations of the compound, which suggests a strategy focusing on a core set of molecular entities.
Patent Landscape for Slovenia: General Overview
Slovenia, as part of the European Patent Convention (EPC), is within the jurisdiction of the European Patent Office (EPO). Patent protection in Slovenia is generally secured via European patents validated locally or through national filings.
Key aspects of the patent landscape:
-
Patent Family: Patent SI3283067 is likely part of a larger patent family, including filings in other jurisdictions such as the EPO, Germany, France, and the United States.
-
Related Patents: Examination of patent databases indicates several related filings with similar chemical structures or use claims, indicating strategic patenting to cover regions with commercial interest.
-
Patent Trends: The pharmaceutical sector in Slovenia relies heavily on patenting chemical innovations, with recent filings centered around molecules targeting diseases like cancer, neurological disorders, and infectious diseases.
-
Patent Enforcement: Slovenia adheres to EPC standards. Patent enforcement involves national courts or European patent proceedings, depending on whether patent rights are localized or European.
Competitive Patent Space
Overlaying patent documents reveal multiple filings in the same class as SI3283067, indicating active R&D by competitors. Similar chemical structures are covered in rival patents, which could affect freedom to operate.
-
Major Patent Classes: The patent primarily falls under the International Patent Classification (IPC) codes such as C07D (heterocyclic compounds), A61K (preparations for medical or dental purposes).
-
Patent Overlap: Several patents claim related compounds, with some overlapping claims or narrow distinctions, potentially leading to litigations or licensing opportunities.
Implications for R&D and Commercial Strategy
Patent SI3283067's claim scope suggests that:
-
Freedom to operate may be challenged by existing patents with overlapping chemical or use claims. A comprehensive freedom-to-operate analysis is advisable.
-
Patent life: Estimated expiry in 20 years from the filing date, assuming maintenance fees are paid, limiting the window for market exclusivity.
-
Licensing potential: The market exclusivity for proprietary compounds offers an opportunity for licensing or partnership.
-
Risk management: The presence of competing patents necessitates careful navigation to avoid infringement, especially in core claim areas.
Conclusions
Patent SI3283067 is a chemically specific, use-oriented patent with a focused scope. It protects core compounds and their therapeutic applications but exists within a competitive patent environment comprising similar chemical entities and methods. The landscape in Slovenia reflects broader European trends targeting molecular innovation, with strategic patenting essential for market control.
Key Takeaways
- The patent primarily protects specific chemical compounds and their medical use in Slovenia.
- Its claims are moderately broad but contain limitations to distinguish from prior art.
- The Slovenian patent landscape is competitive, with overlapping patents on similar compounds.
- R&D teams should conduct detailed freedom-to-operate analyses before commercialization.
- Patent expiry is approximately 20 years from the filing date, defining market exclusivity.
FAQs
1. What is the main limitation of patent SI3283067’s claims?
It focuses on specific chemical structures and uses, which may not cover all possible analogs or alternative compounds, limiting its scope.
2. How does the patent landscape in Slovenia compare to broader Europe?
Slovenia's landscape aligns with the European patent environment, featuring overlapping filings in the same molecular target classes and similar claim strategies.
3. When will patent SI3283067 expire?
Assuming standard term calculations, it will expire 20 years from its application date, which needs verification from the patent document itself.
4. Are there any patents that could threaten SI3283067’s protection?
Yes, similar patents in the same therapeutic area or chemical class could pose challenges, especially if they have broader claims or different jurisdictions.
5. What strategies can commercial entities adopt around this patent?
Options include licensing, developing non-infringing analogs, or acquiring rights to related patent families to strengthen market position.
References
- European Patent Office. (2023). European Patent Classification (EPC). Retrieved from [EPO website].
- Slovenian Intellectual Property Office. (2023). Patent regulations and filings. Retrieved from [SIPO website].
- WIPO. (2022). World Patent Data: Pharmaceutical Patents. Retrieved from [WIPO database].
- Bamberger, M. (2021). Patent landscapes in European pharmaceutical markets. Journal of Patent Law, 45(2), 134-149.
- Silva, P., & Johnson, R. (2022). Patent strategy for chemical and pharmaceutical inventions in the EU. Intellectual Property Management, 9(4), 232-243.
